Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06923423 · ClinicalTrials.gov registry record · NA
Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons
A NA study of Depression and Mental Health, sponsored by University of Arkansas.
- Recruiting
- Registry status
- NA
- Development phase
- 640
- Enrollment target
- 6
- Study locations
NCT06923423: Recruiting NA study of Depression and Mental Health, sponsored by University of Arkansas.
NCT06923423 is a NA study of Depression and Mental Health that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 640 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (18% lower). The trial reports 6 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06923423, a NA study of Depression and Mental Health, is actively recruiting participants, sponsored by University of Arkansas.
- RECRUITING
- Registry status
- NA
- Development phase
- 640 participants
- Enrollment target
- 6
- Study locations
Study Summary
Addiction and trauma exposure are common among the 5.5 million people (1 in 47 adults) in the U.S. who are in prison or under supervision. About 85% of people in prison have a substance use disorder or are there for a drug-related crime, and many have experienced serious trauma before being incarcerated. Posttraumatic stress symptoms (PTSS) are often a result of trauma and are linked to more severe drug use, higher rates of relapse, and increased crime. PTSS and substance use disorder (SUD) each raise the chances of new arrests for people who are justice-involved, showing that addressing trauma and addiction could help reduce repeat offenses and the costs of incarceration. However, treatments for PTSS are rarely available in prisons, and there is little research on whether providing therapy for PTSS in prison can lower drug use, PTSS, or crime after release. The goal of this clinical trial is to see if trauma-focused group therapy (CPT) provided while in prison, can help people after release from prison. The therapy has been adapted for use in prisons (CPT-CJ) and will be compared to trauma focused therapy delivered via a self-help workbook This study will: * test whether a trauma-focused group therapy (CPT-CJ) can reduce post-incarceration drug and alcohol use, mental health issues, and drug-related crime, compared to trauma-focused self-help, * evaluate a strategy called implementation facilitation, which helps support the use of this therapy in prisons, and * measure the cost of the therapies and support strategies to help plan for future expansion. Incarcerated participants (N = 640; 50% female) will be enrolled from \~10 prisons in \~5 states, ensuring variability in population and setting characteristics. They will: * take surveys and answer questions up to 5 times (before starting treatment, right after getting treatment, right before leaving prison, 3 months after leaving prison and 6 months after leaving prison) * complete CPT group therapy or self-hel
Primary Outcome
Participants complete a Timeline Follow Back Interview assessment of illicit drug use during the previous 30 days at 3- \& 6-months post-release from prison. The total number of days of drug use will be summed to represent drug use frequency.
Conditions Studied
Interventions
- BEHAVIORAL Group Cognitive Processing Therapy (CPT)
- BEHAVIORAL Control Group Individual trauma focused self-help via workbook
Study Locations (6)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
- Northeast Arkansas Community Corrections Center (NEACC) - Osceola
- Southwest Arkansas Community Correction Center - Texarkana
- East Central Arkansas Community Correction Center - West Memphis
North Dakota
- North Dakota State Penitentiary (NDSP) - Bismarck
- Heart River Correctional Center (HRCC) - Bismarck
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2025-07-07 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT06923423 shows while recruiting
NCT06923423 is an interventional study that assigns participants to a tested intervention. The registered 640 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 679 other Depression trials with a reported enrollment target (18% lower).
The record links to 10 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Group Cognitive Processing Therapy (CPT) is the first listed.
NCT06923423 lists 6 locations in 2 states (Arkansas, North Dakota).
Frequently Asked Questions
What is clinical trial NCT06923423 about?
NCT06923423 is a clinical study titled "Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons". Addiction and trauma exposure are common among the 5.5 million people (1 in 47 adults) in the U.S. who are in prison or under supervision. About 85% of people in prison have a substance use disorder or are there for a drug-related crime, and many have experienced serious trauma before being incarcer...
What is the current status of trial NCT06923423?
This trial is currently recruiting. It is a NA study. The enrollment target is 640 participants. The study started on 2025-07-07. Estimated completion is 2028-12.
What conditions does trial NCT06923423 study?
This clinical trial studies the following conditions: Depression, Mental Health, Trauma, Substance Use Disorder (SUD), PTSD - Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT06923423?
The interventions under investigation include: Group Cognitive Processing Therapy (CPT) (BEHAVIORAL), Control Group Individual trauma focused self-help via workbook (BEHAVIORAL).
Who is sponsoring clinical trial NCT06923423?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06923423 being conducted?
This trial has 6 study locations across Arkansas, North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06923423's enrollment target sits among peer trials
640 64th of 679 higher than 616 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy